Original Literature | Model OverView |
---|---|
Publication
Title
Toll receptors, CD14, and macrophage activation and deactivation by LPS.
Affiliation
Department of Microbiology and Immunology, Uniformed Services University ofHealth Sciences, 4301 Jones Bridge Road, Bethesda, MD 20814, USA.
Abstract
This review will focus on the molecular mechanisms of macrophage activation anddesensitization by bacterial lipopolysaccharide (LPS). The most recent advancesin the understanding of the function of the LPS receptor complex and its role inthe development of the septic shock syndrome and endotoxin tolerance will bediscussed.
PMID
12106783
|
Entity
--
e1
cso30:c:EntityBiologicalCompartment
cso30:i:CC_PlasmaMembrane
--
--
--
csml-variable:Double
m1
0
infinite
0
--
--
e10
cso30:c:EntityBiologicalCompartment
cso30:i:CC_Cytosol
--
--
--
csml-variable:Double
m10
0
infinite
0
--
LPS:CD14
--
e11
cso30:c:Complex
cso30:i:CC_PlasmaMembrane_ExternalSideOfPlasmaMembrane_
--
csml-variable:Double
m11
0
infinite
0
--
CD14
--
e12
cso30:c:Protein
cso30:i:CC_Extracellular
--
--
csml-variable:Double
m12
0
infinite
0
--
LPS:CD14
--
e13
cso30:c:Complex
cso30:i:CC_Extracellular
--
--
csml-variable:Double
m13
0
infinite
0
--
TLR4
--
e14
cso30:c:Protein
cso30:i:CC_PlasmaMembrane_IntegralToPlasmaMembrane_
--
--
csml-variable:Double
m14
0
infinite
0
--
MD2
--
e15
cso30:c:Protein
cso30:i:CC_Extracellular
--
--
csml-variable:Double
m15
0
infinite
0
--
TLR4:MD2
--
e16
cso30:c:Complex
cso30:i:CC_PlasmaMembrane_IntegralToPlasmaMembrane_
--
csml-variable:Double
m16
0
infinite
0
--
LPS:CD14:TLR4:MD2
--
e17
cso30:c:Complex
cso30:i:CC_PlasmaMembrane_IntegralToPlasmaMembrane_
--
csml-variable:Double
m17
0
infinite
0
--
CD11b:CD18
--
e18
cso30:c:Complex
cso30:i:CC_PlasmaMembrane_IntegralToPlasmaMembrane_
--
--
csml-variable:Double
m18
0
infinite
0
--
LPS:CD11b:CD18
--
e19
cso30:c:Complex
cso30:i:CC_PlasmaMembrane_IntegralToPlasmaMembrane_
--
csml-variable:Double
m19
0
infinite
0
--
--
e2
cso30:c:EntityBiologicalCompartment
cso30:i:CC_PlasmaMembrane_ExternalSideOfPlasmaMembrane_
--
--
--
csml-variable:Double
m2
0
infinite
0
--
CD11c:CD18
--
e20
cso30:c:Complex
cso30:i:CC_PlasmaMembrane_IntegralToPlasmaMembrane_
--
--
csml-variable:Double
m20
0
infinite
0
--
LPS:CD11c:CD18
--
e21
cso30:c:Complex
cso30:i:CC_PlasmaMembrane_ExternalSideOfPlasmaMembrane_
--
csml-variable:Double
m21
0
infinite
0
--
csml-variable:Double
m22
0
infinite
0
--
Nod1
--
e23
cso30:c:Protein
cso30:i:CC_Cytosol
--
--
csml-variable:Double
m23
0
infinite
0
--
LPS:Nod1
--
e24
cso30:c:Complex
cso30:i:CC_Cytosol
--
csml-variable:Double
m24
0
infinite
0
--
CXCR4:GDF5:HSP90:HSP70
--
e25
cso30:c:Complex
cso30:i:CC_PlasmaMembrane_IntegralToPlasmaMembrane_
--
--
csml-variable:Double
m25
0
infinite
0
--
LPS:CXCXR4:GDF5:HSP90:HSP70
--
e26
cso30:c:Complex
cso30:i:CC_PlasmaMembrane_IntegralToPlasmaMembrane_
--
csml-variable:Double
m26
0
infinite
0
--
TNF-alpha
--
e27
cso30:c:mRNA
cso30:i:CC_Nucleoplasm
--
csml-variable:Double
m27
0
infinite
0
--
ERK2
--
e28
cso30:c:Protein
cso30:i:CC_Cytosol
--
csml-variable:Double
m28
0
infinite
0
--
ERK2{active}
--
e29
cso30:c:Protein
cso30:i:CC_Cytosol
--
csml-variable:Double
m29
0
infinite
0
--
--
e3
cso30:c:EntityBiologicalCompartment
cso30:i:CC_PlasmaMembrane_IntegralToPlasmaMembrane_
--
--
--
csml-variable:Double
m3
0
infinite
0
--
NF-kappaB:
--
e30
cso30:c:Protein
cso30:i:CC_Cytosol
--
csml-variable:Double
m30
0
infinite
0
--
NF-kappaB{active}
--
e31
cso30:c:Protein
cso30:i:CC_Cytosol
--
csml-variable:Double
m31
0
infinite
0
--
AP-1
--
e32
cso30:c:Protein
cso30:i:CC_Cytosol
--
csml-variable:Double
m32
0
infinite
0
--
AP-1{active}
--
e33
cso30:c:Protein
cso30:i:CC_Cytosol
--
csml-variable:Double
m33
0
infinite
0
--
NF-kappaB{active}
--
e34
cso30:c:Protein
cso30:i:CC_Nucleoplasm
--
csml-variable:Double
m34
0
infinite
0
--
IL-12p40
--
e35
cso30:c:mRNA
cso30:i:CC_Nucleoplasm
--
--
csml-variable:Double
m35
0
infinite
0
--
MCP-5
--
e36
cso30:c:mRNA
cso30:i:CC_Nucleoplasm
--
--
csml-variable:Double
m36
0
infinite
0
--
IFN-gamma
--
e37
cso30:c:mRNA
cso30:i:CC_Nucleoplasm
--
--
csml-variable:Double
m37
0
infinite
0
--
TLR2
--
e38
cso30:c:Protein
cso30:i:CC_PlasmaMembrane_IntegralToPlasmaMembrane_
--
csml-variable:Double
m38
0
infinite
0
--
csml-variable:Double
m39
0
infinite
0
--
--
e4
cso30:c:EntityBiologicalCompartment
cso30:i:CC_PlasmaMembrane_InternalSideOfPlasmaMembrane_
--
--
--
csml-variable:Double
m4
0
infinite
0
--
LAM:TLR2
--
e40
cso30:c:Complex
cso30:i:CC_PlasmaMembrane_IntegralToPlasmaMembrane_
--
csml-variable:Double
m40
0
infinite
0
--
csml-variable:Double
m41
0
infinite
0
--
STF:TLR2
--
e42
cso30:c:Complex
cso30:i:CC_PlasmaMembrane_IntegralToPlasmaMembrane_
--
csml-variable:Double
m42
0
infinite
0
--
IL-8
--
e43
cso30:c:mRNA
cso30:i:CC_Nucleoplasm
--
--
csml-variable:Double
m43
0
infinite
0
--
csml-variable:Double
m44
0
infinite
0
--
LPS:TLR2
--
e45
cso30:c:Complex
cso30:i:CC_PlasmaMembrane_IntegralToPlasmaMembrane_
--
--
csml-variable:Double
m45
0
infinite
0
--
cox2
--
e46
cso30:c:mRNA
cso30:i:CC_Nucleoplasm
--
--
csml-variable:Double
m46
0
infinite
0
--
csml-variable:Double
m47
0
infinite
0
--
IP-10
--
e48
cso30:c:mRNA
cso30:i:CC_Nucleoplasm
--
--
csml-variable:Double
m48
0
infinite
0
--
csml-variable:Double
m49
0
infinite
0
--
LPS
--
e5
cso30:c:SmallMolecule
cso30:i:CC_Extracellular
--
csml-variable:Double
m5
0
infinite
0
--
--
e50
cso30:c:EntityBiologicalCompartment
cso30:i:CC_NuclearEnvelopeLumen
--
--
--
csml-variable:Double
m50
0
infinite
0
--
--
e51
cso30:c:EntityBiologicalCompartment
cso30:i:CC_NuclearPore
--
--
--
csml-variable:Double
m51
0
infinite
0
--
--
e52
cso30:c:EntityBiologicalCompartment
cso30:i:CC_NuclearInnerMembrane
--
--
--
csml-variable:Double
m52
0
infinite
0
--
--
e53
cso30:c:EntityBiologicalCompartment
cso30:i:CC_NuclearLumen
--
--
--
csml-variable:Double
m53
0
infinite
0
--
--
e54
cso30:c:EntityBiologicalCompartment
cso30:i:CC_NuclearOuterMembrane
--
--
--
csml-variable:Double
m54
0
infinite
0
--
--
e55
cso30:c:EntityBiologicalCompartment
cso30:i:CC_Nucleus
--
--
--
csml-variable:Double
m55
0
infinite
0
--
--
e56
cso30:c:EntityBiologicalCompartment
cso30:i:CC_Nucleoplasm
--
--
--
csml-variable:Double
m56
0
infinite
0
--
--
e57
cso30:c:EntityBiologicalCompartment
cso30:i:CC_NuclearBody
--
--
--
csml-variable:Double
m57
0
infinite
0
--
--
e58
cso30:c:EntityBiologicalCompartment
cso30:i:CC_Nucleolus
--
--
--
csml-variable:Double
m58
0
infinite
0
--
--
e59
cso30:c:EntityBiologicalCompartment
cso30:i:CC_NuclearEnvelope
--
--
--
csml-variable:Double
m59
0
infinite
0
--
CD14
--
e6
cso30:c:Protein
cso30:i:CC_Extracellular
--
--
csml-variable:Double
m6
0
infinite
0
--
--
e60
cso30:c:EntityBiologicalCompartment
cso30:i:CC_Chromatin
--
--
--
csml-variable:Double
m60
0
infinite
0
--
--
e61
cso30:c:EntityBiologicalCompartment
cso30:i:CC_NuclearChromosome
--
--
--
csml-variable:Double
m61
0
infinite
0
--
--
e62
cso30:c:EntityBiologicalCompartment
cso30:i:CC_NuclearCentromere
--
--
--
csml-variable:Double
m62
0
infinite
0
--
ICSBP
--
e63
cso30:c:mRNA
cso30:i:CC_Nucleolus
--
--
csml-variable:Double
m63
0
infinite
0
--
IKKalpha:IKKbeta:IKKgamma
--
e64
cso30:c:Complex
cso30:i:CC_Cytosol
--
--
csml-variable:Double
m64
0
infinite
0
--
IKKalpha:Ikkbeta:IKKgamma{active}
--
e65
cso30:c:Complex
cso30:i:CC_Cytosol
--
csml-variable:Double
m65
0
infinite
0
--
Ikappa-B:NF-kappaB
--
e66
cso30:c:Complex
cso30:i:CC_Cytosol
--
--
csml-variable:Double
m66
0
infinite
0
--
csml-variable:Double
m67
0
infinite
0
--
Ikappa-B{ub}{NF-kappaB
--
e68
cso30:c:Protein
cso30:i:CC_Cytosol
--
csml-variable:Double
m68
0
infinite
0
--
protein remnants
--
e69
cso30:c:EntityBiological
cso30:i:CC_Cytosol
--
--
csml-variable:Double
m69
0
infinite
0
--
--
e7
cso30:c:EntityBiologicalCompartment
cso30:i:CC_Cell
--
--
--
csml-variable:Double
m7
0
infinite
0
--
I-kappaB
--
e70
cso30:c:mRNA
cso30:i:CC_Nucleoplasm
--
--
csml-variable:Double
m70
0
infinite
0
--
csml-variable:Double
m71
0
infinite
0
--
csml-variable:Double
m72
0
infinite
0
--
csml-variable:Double
m73
0
infinite
0
--
csml-variable:Double
m74
0
infinite
0
--
csml-variable:Double
m75
0
infinite
0
--
csml-variable:Double
m76
0
infinite
0
--
csml-variable:Double
m77
0
infinite
0
--
csml-variable:Double
m78
0
infinite
0
--
--
e8
cso30:c:EntityBiologicalCompartment
cso30:i:CC_Cell_WithoutCellWall_
--
--
--
csml-variable:Double
m8
0
infinite
0
--
--
e9
cso30:c:EntityBiologicalCompartment
cso30:i:CC_Cytoplasm
--
--
--
csml-variable:Double
m9
0
infinite
0
--
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c1 : 1
stoichiometry:c2 : 1
stoichiometry:c3 : 1
m6*m5*0.1
nodelay
--
0
PMID: 12106783 LPS is bound by CD14 and/or CD11/18 at the cell surface and facilitates an interaction with the TLR4-MD2 complex.
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c26 : 1
stoichiometry:c27 : 1
stoichiometry:c28 : 1
m25*m5*0.1
nodelay
--
0
PMID: 12106783 The CD14-independent cluster able to bind to LPS and represented by Hsp70, Hsp-90, CXCR4, and GDF5 may also contribute to LPS-induced TNF-¦Á production by as yet unknown mechanism(s).
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c64 : 1
stoichiometry:c29 : 1
m17*0.1
nodelay
--
0
PMID: 12106783 Induction of a panel of inflammatory genes including COX-2, IL-12 p35, IL-12 p40, TNF-¦Á, IP-10, IRF-1, and ICSBP by low concentrations of LPS required both CD14 and TLR4.
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c31 : 1
stoichiometry:c54 : 1
stoichiometry:c32 : 1
m28*m42*0.1
nodelay
--
0
PMID: 12106783 E. coli LPS and the TLR2 agonists, lipoarabinomannan (LAM) and soluble tuberculosis factor (STF), rapidly activated mitogen activated (MAP) kinases, as well as NF-¦ÊB and AP-1 transactivation.
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c35 : 1
stoichiometry:c37 : 1
stoichiometry:c36 : 1
m32*m17*0.1
nodelay
--
0
PMID: 12106783 E. coli LPS and the TLR2 agonists, lipoarabinomannan (LAM) and soluble tuberculosis factor (STF), rapidly activated mitogen activated (MAP) kinases, as well as NF-¦ÊB and AP-1 transactivation.
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c38 : 1
stoichiometry:c41 : 1
stoichiometry:c39 : 1
m31*m21*0.1
nodelay
--
0
PMID: 12106783, 9200483, 7535339, 9820516 CD18 in complex with CD11b or CD11c, activates signaling cascades leading to NF-¦ÊB translocation.
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c43 : 1
stoichiometry:c42 : 1
m17*0.1
nodelay
--
0
PMID: 12106783 IFN-¦Ã, IL-12 p40, and MCP-5 were induced only by E. coli LPS. Induction of a panel of inflammatory genes including COX-2, IL-12 p35, IL-12 p40, TNF-¦Á, IP-10, IRF-1, and ICSBP by low concentrations of LPS required both CD14 and TLR4.
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c45 : 1
stoichiometry:c44 : 1
m17*0.1
nodelay
--
0
PMID: 12106783 IFN-¦Ã, IL-12 p40, and MCP-5 were induced only by E. coli LPS.
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c47 : 1
stoichiometry:c46 : 1
m17*0.1
nodelay
--
0
PMID: 12106783 IFN-¦Ã, IL-12 p40, and MCP-5 were induced only by E. coli LPS
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c48 : 1
stoichiometry:c49 : 1
stoichiometry:c50 : 1
m38*m39*0.1
nodelay
--
0
PMID: 12106783 E. coli LPS and the TLR2 agonists, lipoarabinomannan (LAM) and soluble tuberculosis factor (STF), rapidly activated mitogen activated (MAP) kinases, as well as NF-¦ÊB and AP-1 transactivation.
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c51 : 1
stoichiometry:c52 : 1
stoichiometry:c53 : 1
m41*m38*0.1
nodelay
--
0
PMID: 12106783 E. coli LPS and the TLR2 agonists, lipoarabinomannan (LAM) and soluble tuberculosis factor (STF), rapidly activated mitogen activated (MAP) kinases, as well as NF-¦ÊB and AP-1 transactivation.
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c4 : 1
stoichiometry:c5 : 1
stoichiometry:c6 : 1
m5*m12*0.1
nodelay
--
0
PMID: 12106783, 1698311, 7534290, 7534291 soluble form (sCD14) or a glycosylphosphatidylinositol (GPI)-linked form (mCD14) on myeloid lineage cells bound enterobacterial LPS with high affinity.
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c61 : 1
stoichiometry:c60 : 1
m42*0.1
nodelay
--
0
PMID: 12106783 Activation of DC through TLR2 also led to preferential induction of IL-8 and p19/IL-23.
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c63 : 1
stoichiometry:c62 : 1
m42*0.1
nodelay
--
0
PMID: 12106783 Activation of DC through TLR2 also led to preferential induction of IL-8 and p19/IL-23.
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c65 : 1
stoichiometry:c66 : 1
stoichiometry:c67 : 1
m38*m5*0.1
nodelay
--
0
PMID: 12106783, 9751057 LPS binding ability of TLRs revealed that 3H-labeled LPS bound TLR2. However, the kinetics of association was slow and the Kd low (500?700 nM).
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c70 : 1
stoichiometry:c69 : 1
m17*0.1
nodelay
--
0
PMID: 12106783 Induction of a panel of inflammatory genes including COX-2, IL-12 p35, IL-12 p40, TNF-¦Á, IP-10, IRF-1, and ICSBP by low concentrations of LPS required both CD14 and TLR4.
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c71 : 1
stoichiometry:c72 : 1
m17*0.1
nodelay
--
0
PMID: 12106783 Induction of a panel of inflammatory genes including COX-2, IL-12 p35, IL-12 p40, TNF-¦Á, IP-10, IRF-1, and ICSBP by low concentrations of LPS required both CD14 and TLR4.
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c74 : 1
stoichiometry:c73 : 1
m17*0.1
nodelay
--
0
PMID: 12106783 Induction of a panel of inflammatory genes including COX-2, IL-12 p35, IL-12 p40, TNF-¦Á, IP-10, IRF-1, and ICSBP by low concentrations of LPS required both CD14 and TLR4.
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c76 : 1
stoichiometry:c75 : 1
m17*0.1
nodelay
--
0
PMID: 12106783 Induction of a panel of inflammatory genes including COX-2, IL-12 p35, IL-12 p40, TNF-¦Á, IP-10, IRF-1, and ICSBP by low concentrations of LPS required both CD14 and TLR4.
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c78 : 1
stoichiometry:c77 : 1
m17*0.1
nodelay
--
0
PMID: 12106783 Induction of a panel of inflammatory genes including COX-2, IL-12 p35, IL-12 p40, TNF-¦Á, IP-10, IRF-1, and ICSBP by low concentrations of LPS required both CD14 and TLR4.
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c81 : 1
stoichiometry:c34 : 1
stoichiometry:c80 : 1
m17*m64*0.1
nodelay
--
0
PMID: 12106783 Stimulation of cells with LPS or other inflammatory stimuli leads to the activation of the I¦ÊB kinase complex (IKK).
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c100 : 1
stoichiometry:c102 : 1
stoichiometry:c101 : 1
m75*m17*0.1
nodelay
--
0
PMID: 12106783 In addition to NF-¦ÊB, LPS also activates MAP kinases, including JNK-1/2, ERK-1/2, and p38, in macrophages.
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c7 : 1
stoichiometry:c8 : 1
stoichiometry:c9 : 1
m14*m15*0.1
nodelay
--
0
PMID: 12106783 LPS is bound by CD14 and/or CD11/18 at the cell surface and facilitates an interaction with the TLR4-MD2 complex.
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c82 : 1
stoichiometry:c84 : 1
stoichiometry:c83 : 1
m66*m65*0.1
nodelay
--
0
PMID: 12106783 Stimulation of cells with LPS or other inflammatory stimuli leads to the activation of the I¦ÊB kinase complex (IKK), which phosphorylates I¦ÊB on two N-terminal serine residues.
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c85 : 1
stoichiometry:c86 : 1
m67*0.1
nodelay
--
0
PMID: 12106783 Phosphorylated I¦ÊB becomes a substrate for ubiquitin ligase and finally undergoes degradation by the 26S proteasome.
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c87 : 1
stoichiometry:c88 : 1
stoichiometry:c89 : 1
m68*0.1
nodelay
--
0
PMID: 12106783 Phosphorylated I¦ÊB becomes a substrate for ubiquitin ligase and finally undergoes degradation by the 26S proteasome.
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c90 : 1
stoichiometry:c91 : 1
m34*0.1
nodelay
--
0
PMID: 12106783 Released NF-¦ÊB then moves to the nucleus, where it activates the transcription of many ¦ÊB-dependent genes, including TNF-¦Á and I¦ÊB¦Á.
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c92 : 1
stoichiometry:c94 : 1
stoichiometry:c93 : 1
m71*m17*0.1
nodelay
--
0
PMID: 12106783 In addition to NF-¦ÊB, LPS also activates MAP kinases, including JNK-1/2, ERK-1/2, and p38, in macrophages.
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c55 : 1
stoichiometry:c96 : 1
stoichiometry:c95 : 1
m73*m17*0.1
nodelay
--
0
PMID: 12106783 In addition to NF-¦ÊB, LPS also activates MAP kinases, including JNK-1/2, ERK-1/2, and p38, in macrophages.
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c104 : 1
stoichiometry:c106 : 1
stoichiometry:c105 : 1
m77*m17*0.1
nodelay
--
0
PMID: 12106783 In addition to NF-¦ÊB, LPS also activates MAP kinases, including JNK-1/2, ERK-1/2, and p38, in macrophages.
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c108 : 1
stoichiometry:c19 : 1
stoichiometry:c109 : 1
m28*m17*0.1
nodelay
--
0
PMID: 12106783 In addition to NF-¦ÊB, LPS also activates MAP kinases, including JNK-1/2, ERK-1/2, and p38, in macrophages.
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c111 : 1
stoichiometry:c110 : 1
m26*0.1
nodelay
--
0
PMID: 12106783 The CD14-independent cluster able to bind to LPS and represented by Hsp70, Hsp-90, CXCR4, and GDF5 may also contribute to LPS-induced TNF-¦Á production by as yet unknown mechanism(s). Induction of a panel of inflammatory genes including COX-2, IL-12 p35, IL-12 p40, TNF-¦Á, IP-10, IRF-1, and ICSBP by low concentrations of LPS required both CD14 and TLR4. Released NF-¦ÊB then moves to the nucleus, where it activates the transcription of many ¦ÊB-dependent genes, including TNF-¦Á and I¦ÊB¦Á. MAP kinases have been shown to be important for both TNF-¦Á and IL-1 synthesis
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c112 : 1
stoichiometry:c30 : 1
m34*0.1
nodelay
--
0
PMID: 12106783 Released NF-¦ÊB then moves to the nucleus, where it activates the transcription of many ¦ÊB-dependent genes, including TNF-¦Á and I¦ÊB¦Á.
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c10 : 1
stoichiometry:c11 : 1
stoichiometry:c12 : 1
m11*m16*0.1
nodelay
--
0
PMID: 12106783 LPS is bound by CD14 and/or CD11/18 at the cell surface and facilitates an interaction with the TLR4-MD2 complex.
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c113 : 1
stoichiometry:c79 : 1
m78*0.1
nodelay
--
0
PMID: 12106783 Induction of a panel of inflammatory genes including COX-2, IL-12 p35, IL-12 p40, TNF-¦Á, IP-10, IRF-1, and ICSBP by low concentrations of LPS required both CD14 and TLR4. MAP kinases have been shown to be important for both TNF-¦Á and IL-1 synthesis
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c114 : 1
stoichiometry:c107 : 1
m76*0.1
nodelay
--
0
PMID: 12106783 Induction of a panel of inflammatory genes including COX-2, IL-12 p35, IL-12 p40, TNF-¦Á, IP-10, IRF-1, and ICSBP by low concentrations of LPS required both CD14 and TLR4. MAP kinases have been shown to be important for both TNF-¦Á and IL-1 synthesis
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c117 : 1
stoichiometry:c103 : 1
m72*0.1
nodelay
--
0
PMID: 12106783 Induction of a panel of inflammatory genes including COX-2, IL-12 p35, IL-12 p40, TNF-¦Á, IP-10, IRF-1, and ICSBP by low concentrations of LPS required both CD14 and TLR4. MAP kinases have been shown to be important for both TNF-¦Á and IL-1 synthesis
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c116 : 1
stoichiometry:c115 : 1
m29*0.1
nodelay
--
0
PMID: 12106783 Induction of a panel of inflammatory genes including COX-2, IL-12 p35, IL-12 p40, TNF-¦Á, IP-10, IRF-1, and ICSBP by low concentrations of LPS required both CD14 and TLR4. MAP kinases have been shown to be important for both TNF-¦Á and IL-1 synthesis
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c98 : 1
stoichiometry:c97 : 1
m74*0.1
nodelay
--
0
PMID: 12106783 Induction of a panel of inflammatory genes including COX-2, IL-12 p35, IL-12 p40, TNF-¦Á, IP-10, IRF-1, and ICSBP by low concentrations of LPS required both CD14 and TLR4. MAP kinases have been shown to be important for both TNF-¦Á and IL-1 synthesis
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c99 : 1
stoichiometry:c122 : 1
stoichiometry:c118 : 1
m32*m42*0.1
nodelay
--
0
PMID: 12106783 E. coli LPS and the TLR2 agonists, lipoarabinomannan (LAM) and soluble tuberculosis factor (STF), rapidly activated mitogen activated (MAP) kinases, as well as NF-¦ÊB and AP-1 transactivation.
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c119 : 1
stoichiometry:c121 : 1
stoichiometry:c120 : 1
m32*m40*0.1
nodelay
--
0
PMID: 12106783 E. coli LPS and the TLR2 agonists, lipoarabinomannan (LAM) and soluble tuberculosis factor (STF), rapidly activated mitogen activated (MAP) kinases, as well as NF-¦ÊB and AP-1 transactivation.
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c58 : 1
stoichiometry:c123 : 1
stoichiometry:c59 : 1
m31*m19*0.1
nodelay
--
0
PMID: 12106783, 9200483, 7535339, 9820516 CD18 in complex with CD11b or CD11c, activates signaling cascades leading to NF-¦ÊB translocation.
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c40 : 1
stoichiometry:c127 : 1
stoichiometry:c124 : 1
m30*m40*0.1
nodelay
--
0
PMID: 12106783 E. coli LPS and the TLR2 agonists, lipoarabinomannan (LAM) and soluble tuberculosis factor (STF), rapidly activated mitogen activated (MAP) kinases, as well as NF-¦ÊB and AP-1 transactivation.
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c125 : 1
stoichiometry:c128 : 1
stoichiometry:c126 : 1
m30*m24*0.1
nodelay
--
0
PMID: 12106783 Nod 1 binds to 3H?LPS and activates NF-¦ÊB in a TLR4-independent fashion.
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c13 : 1
stoichiometry:c14 : 1
stoichiometry:c15 : 1
m18*m5*0.1
nodelay
--
0
PMID: 12106783, 2462607 CD11b/CD18 (Mac-1) and CD11c/CD18, obligate heterodimers share a common molecule, CD18, which was shown to be necessary for LPS binding on the surface of cells expressing integrins.
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c16 : 1
stoichiometry:c17 : 1
stoichiometry:c18 : 1
m5*m20*0.1
nodelay
--
0
PMID: 12106783, 2462607 CD11b/CD18 (Mac-1) and CD11c/CD18, obligate heterodimers share a common molecule, CD18, which was shown to be necessary for LPS binding on the surface of cells expressing integrins.
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c20 : 1
stoichiometry:c56 : 1
stoichiometry:c33 : 1
m30*m42*0.1
nodelay
--
0
PMID: 12106783 E. coli LPS and the TLR2 agonists, lipoarabinomannan (LAM) and soluble tuberculosis factor (STF), rapidly activated mitogen activated (MAP) kinases, as well as NF-¦ÊB and AP-1 transactivation.
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c21 : 1
stoichiometry:c22 : 1
m5*0.1
nodelay
--
0
PMID: 12106783 LPS can also be internalized through an as yet unknown mechanism.
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c23 : 1
stoichiometry:c24 : 1
stoichiometry:c25 : 1
m23*m22*0.1
nodelay
--
0
PMID: 12106783 LPS can also be internalized through an as yet unknown mechanism, and may bind to intracellular Nod1.
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--